Comparison of aromatase inhibitor (letrozole) and immunomodulators (infliximab and etanercept) on the regression of endometriotic implants in a rat model

Seyit Temel Ceyhan; Onder Onguru; Önder Öngürü; Ulaş Fidan; Ulas Fidan; Tayfun Ide; Halil Yaman; Halıl Yaman; Selim Kılıç; Selim Kilic; İskender Başer; Iskender Baser

doi:10.1016/j.ejogrb.2010.09.003

Comparison of aromatase inhibitor (letrozole) and immunomodulators (infliximab and etanercept) on the regression of endometriotic implants in a rat model

Seyit Temel Ceyhan, Onder Onguru, Önder Öngürü, Ulaş Fidan, Ulas Fidan, Tayfun Ide, Halil Yaman, Halıl Yaman, Selim Kılıç, Selim Kilic, İskender Başer, Iskender Baser

European journal of obstetrics, gynecology, and reproductive biology · 2010 · vol. 154(1) , pp. 100–104 · doi:10.1016/j.ejogrb.2010.09.003 · PMID:21035240 · W2080665124

article OA: closed CC0 ⤵ 29 in-corpus citations

Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".

View at publisher → View on OpenAlex View on PubMed

⚙ AI-generated summary by claude@2026-06, 2026-06-08 ⓘ

This study investigated the effects of letrozole, infliximab, and etanercept on endometriotic implant regression in rats, finding that letrozole was most effective.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Antibodies, Monoclonal Aromatase Inhibitors Endometriosis Immunoglobulin G Immunologic Factors Nitriles Receptors, Tumor Necrosis Factor Triazoles Animals Antibodies, Monoclonal Aromatase Inhibitors Ascitic Fluid Ascitic Fluid Disease Models, Animal Endometriosis Endometriosis Etanercept Female Immunoglobulin G Immunologic Factors

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (29)

Cited by (29)

Source provenance

europepmc: last seen: 2026-06-11T06:19:48.454388+00:00
openalex: last seen: 2026-06-10T17:14:06.276822+00:00
pubmed: last seen: 2026-05-13T22:17:00.782903+00:00

License: CC0 · commercial use OK

[1] Aromatase expression in endometriosis via openalex

[2] Aromatase expression in endometriosis. via openalex

[3] Aromatase in endometriosis and uterine leiomyomata via openalex

[4] Changes in the T-helper cytokine profile and in lymphocyte activation at the systemic and local levels in women with endometriosis via openalex

[5] Deficient 17 -Hydroxysteroid Dehydrogenase Type 2 Expression in Endometriosis: Failure to Metabolize 17 -Estradiol via openalex

[6] Deficient 17β-Hydroxysteroid Dehydrogenase Type 2 Expression in Endometriosis: Failure to Metabolize 17β-Estradiol<sup>1</sup> via openalex

[7] Effect of the immunomodulator leflunomide on the induction of endometriosis in an experimental rat model via openalex

[8] Efficacy of anti-tumor necrosis factor therapy in the treatment of spontaneous endometriosis in baboons via openalex

[9] Endometrial and peritoneal expression of aromatase, cytokines, and adhesion factors in women with endometriosis via openalex

[10] ENDOMETRIOSIS via openalex

[11] Estrogen production in endometriosis and use of aromatase inhibitors to treat endometriosis. via openalex

[12] Expression of cyclooxygenase-2 and vascular endothelial growth factor in ovarian endometriotic cysts and their relationship with angiogenesis via openalex

[13] Expression of GnRH receptor gene in human ectopic endometrial cells and inhibition of their proliferation by leuprolide acetate via openalex

[14] High-dose atorvastatin causes regression of endometriotic implants: a rat model via openalex

[15] Induction of an angiogenic phenotype in endometriotic stromal cell cultures by interleukin-1 via openalex

[16] Inhibitory effects of a novel aromatase inhibitor, YM511, on growth of endometrial explants and insulin-like growth factor-I gene expression in rats with experimental endometriosis via openalex

[17] Morphometric study of the stromal vascularization in peritoneal endometriosis via openalex

[18] Ovarian steroid regulation of vascular endothelial growth factor in the human endometrium: implications for angiogenesis during the menstrual cycle and in the pathogenesis of endometriosis via openalex

[19] Ovarian steroid regulation of vascular endothelial growth factor in the human endometrium: implications for angiogenesis during the menstrual cycle and in the pathogenesis of endometriosis. via openalex

[20] Pentoxifylline versus placebo in the treatment of infertility associated with minimal or mild endometriosis: a pilot randomized clinical trial via openalex

[21] Recombinant Human TNFRSF1A (r-hTBP1) Inhibits the Development of Endometriosis in Baboons: A Prospective, Randomized, Placebo- and Drug-Controlled Study1 via openalex

[22] Role of cytokines in endometriosis via openalex

[23] The Role of Cytokines in Endometriosis* via openalex

[24] Vascular endothelial growth factor is produced by peritoneal fluid macrophages in endometriosis and is regulated by ovarian steroids. via openalex

[25] W2414422650 via openalex

[26] W2140246703 via openalex

[27] W1988258332 via openalex

[28] W2628053793 via openalex

[29] W2284473629 via openalex